---
figid: PMC9700086__NRR-18-727-g003
figtitle: 'Agomelatine: a potential novel approach for the treatment of memory disorder
  in neurodegenerative disease'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9700086
filename: NRR-18-727-g003.jpg
figlink: /pmc/articles/PMC9700086/figure/F1/
number: F1
caption: 'Pathways involving the neuroprotective effects of AGO (schematic).Through
  MT1/MT2, AGO can activate PI3K-AKT-GSK3β and MAPK-ERK1/2-RSK90-CREB cascades, which
  control gene transcription or protein modification. Activation of GSK3β inhibits
  tau phosphorylation. CREB can control BDNF transcription. By inhibiting the 5-HT2C
  receptor (5-HT2CR), AGO can also inhibit IP3 from releasing Ca2+ from the endoplasmic
  reticulum, and promote expression of BDNF which combined with TrkB and activate
  the MAPK-ERK1/2-RSK90-CREB signaling pathway. 5-HT2C: 5-Hydroxytryptamine 2C; AGO:
  agomelatine; AKT: protein kinase B; BDNF: brain-derived neurotrophic factor; CREB:
  cyclic adenosine monophosphate-response element binding protein; ERK: extracellular
  signal-related kinase; GSK3β: glycogen synthase kinase 3β; IP3: inositol 1,4,5-trisphosphate;
  MAPK: mitogen-activated protein kinases; MT1: melatonin receptor 1A; MT2: melatonin
  receptor 1B; PI3K: phosphatidylinositol-3-kinase; RSK90: 90 kDa ribosomal s6 kinase;
  TrkB: tropomyosin-related kinase B.'
papertitle: 'Agomelatine: a potential novel approach for the treatment of memory disorder
  in neurodegenerative disease.'
reftext: Qiang Su, et al. Neural Regen Res. 2023 Apr;18(4):727-733.
year: '2023'
doi: 10.4103/1673-5374.353479
journal_title: Neural Regeneration Research
journal_nlm_ta: Neural Regen Res
publisher_name: Wolters Kluwer - Medknow
keywords: agomelatine | antidepressant | anxiety | apathy | circadian-rhythm sleep
  disorder | cognitive impairment | depression | melatonergic | memory disorder |
  mood disorder | neurodegenerative disease
automl_pathway: 0.8753229
figid_alias: PMC9700086__F1
figtype: Figure
redirect_from: /figures/PMC9700086__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9700086__NRR-18-727-g003.html
  '@type': Dataset
  description: 'Pathways involving the neuroprotective effects of AGO (schematic).Through
    MT1/MT2, AGO can activate PI3K-AKT-GSK3β and MAPK-ERK1/2-RSK90-CREB cascades,
    which control gene transcription or protein modification. Activation of GSK3β
    inhibits tau phosphorylation. CREB can control BDNF transcription. By inhibiting
    the 5-HT2C receptor (5-HT2CR), AGO can also inhibit IP3 from releasing Ca2+ from
    the endoplasmic reticulum, and promote expression of BDNF which combined with
    TrkB and activate the MAPK-ERK1/2-RSK90-CREB signaling pathway. 5-HT2C: 5-Hydroxytryptamine
    2C; AGO: agomelatine; AKT: protein kinase B; BDNF: brain-derived neurotrophic
    factor; CREB: cyclic adenosine monophosphate-response element binding protein;
    ERK: extracellular signal-related kinase; GSK3β: glycogen synthase kinase 3β;
    IP3: inositol 1,4,5-trisphosphate; MAPK: mitogen-activated protein kinases; MT1:
    melatonin receptor 1A; MT2: melatonin receptor 1B; PI3K: phosphatidylinositol-3-kinase;
    RSK90: 90 kDa ribosomal s6 kinase; TrkB: tropomyosin-related kinase B.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tau
  - Mt2
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - up
  - Akt
  - sgg
  - Axn
  - gskt
  - rl
  - ago
  - AGO1
  - AGO2
  - CrebB
  - CrebA
  - Itpr
  - NetA
  - NetB
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - MAPT
  - MT1A
  - MT1B
  - MT1E
  - MT1F
  - MT1G
  - MT1H
  - MT1JP
  - MT1M
  - MT1L
  - MT1X
  - MTNR1A
  - ALG1
  - MT1IP
  - MT2A
  - MTNR1B
  - TMPRSS6
  - MAP2K1
  - SERPINB1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - INTU
  - AKT1
  - AKT2
  - AKT3
  - GSK3B
  - MAPK3
  - MAPK1
  - FBXW7
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - BDNF
  - BDNF-AS
  - NTRK2
  - ITPR1
  - ITPR3
  - NTN1
  - NTN3
  - NTN4
  - Ba
  - Ca2+
  - Neuronal damage  Memory and cognitive impairment  Mental disorder
---
